Search results
US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment
Reuters· 14 minutes agoThe U.S. Food and Drug Administration approved on Tuesday Amgen's Bkemv, the first biosimilar to AstraZeneca's rare blood disorder treatment Soliris.
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 1 day agoAmgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...
It's Unlikely That Amgen Inc.'s (NASDAQ:AMGN) CEO Will See A Huge Pay Rise This Year
Simply Wall St. via Yahoo Finance· 3 days ago(NASDAQ:AMGN) over the last few years, earnings growth has been disappointing, which suggests...
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.55%
Investing.com· 17 hours agoU.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.55%
Amgen's Catching Up to Novo Nordisk and Eli Lilly. Should You Buy It?
Motley Fool via Yahoo Finance· 2 days agoWith some promising clinical trial results in hand and more that could be on the way relatively...
Recent Insider Activity Could Benefit AMGEN Inc.
Knox Daily· 7 days agoAs a result of the transaction, Graham Jonathan P now holds 28,078 shares, worth roughly $8.84 million. William Blair upgraded its AMGEN Inc. [AMGN] rating to an Outperform ...
Eli Lilly (LLY) to Ramp Up Indiana Site for Mounjaro, Zepbound
Zacks via Yahoo Finance· 1 day agoSince 2020, Eli Lilly (LLY) has committed more than $18 billion to building new manufacturing sites...
Markets News, May 28, 2024: Nvidia Soars to Record; Rising Treasury Yields Weigh on Dow
Investopedia· 2 hours agoU.S. stocks were mixed Tuesday, with Nvidia and other AI stocks sending the Nasdaq to a record close...
Top Stock Reports for Apple, Mastercard & Amgen
Zacks via Yahoo Finance· 5 days agoToday's Research Daily features new research reports on 16 major stocks, including Apple (AAPL), Mastercard (MA) and Amgen (AMGN), as well as two...
Obesity Drug Stocks: Where to Invest Now
Morningstar· 3 hours agoPharmaceutical investing has seen huge moves in the industry’s stocks over the past year, with one area grabbing particular attention: obesity drugs....
